Crescita Therapeutics Inc.
CRRTF
$0.36
$0.01273.66%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -947.90K | -2.20M | -2.02M | -2.01M | -2.21M |
| Total Depreciation and Amortization | 990.60K | 957.70K | 997.30K | 1.02M | 1.07M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.70K | 144.50K | 143.10K | 236.30K | 190.20K |
| Change in Net Operating Assets | 882.80K | 2.44M | 2.85M | 1.56M | 1.53M |
| Cash from Operations | 934.30K | 1.34M | 1.97M | 799.20K | 581.50K |
| Capital Expenditure | -1.03M | -1.57M | -1.53M | -1.35M | -764.60K |
| Sale of Property, Plant, and Equipment | 57.20K | 57.20K | 57.20K | 57.20K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -973.90K | -1.52M | -1.47M | -1.30M | -764.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -455.00K | -449.00K | -441.00K | -433.00K | -426.00K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 19.00K |
| Repurchase of Common Stock | -296.00K | -285.00K | -320.00K | -396.00K | -519.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -50.00K | -50.00K | -100.00K | -50.00K | -50.00K |
| Cash from Financing | -575.10K | -564.10K | -628.30K | -646.50K | -721.70K |
| Foreign Exchange rate Adjustments | 22.40K | 29.60K | 30.50K | -15.40K | 13.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -592.30K | -715.70K | -95.30K | -1.16M | -891.30K |